TOKYO - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced formulation of CHUGAI DIGITAL VISION 2030 for a digital transformation clearly distinct from earlier digitalization efforts.

Rapid advances in IT and digital technology enabled new scientific methods utilizing means including artificial intelligence (AI), real-world data (RWD) and real-world evidence (RWE). Moreover, amid growing measures to contain healthcare costs, there is increasing need for pharmaceutical products with true value for patients. Chugai has formulated CHUGAI DIGITAL VISION 2030 for a digital transformation clearly distinct from earlier digitalization efforts. It aims to realize business transformation by digital technologies and provide society-changing healthcare solution.

'In CHUGAI DIGITAL VISION 2030, Chugai has set its goal for 2030 to transform our business by using digital technologies to make Chugai a top innovator in the provision of society-changing healthcare solutions,' said Satoko Shisai, Chugai's Vice President, General Manager of Digital & IT Supervisory Division. 'Our three basic strategies consisting of; 1) Strengthen digital platform, 2) Optimize all value chains, and 3) Digital transformation for drug discovery and development, aims to accelerate the advancement of society and Chugai by generating innovation focused on novel drugs.'

Contact:

Tomoko Shimizu

Tel: +81-3-3273-0881

Email: pr@chugai-pharm.co.jp

(C) 2020 Electronic News Publishing, source ENP Newswire